Last update 01 Nov 2024

HDAC6 x KDM1A x HDAC8

Basic Info

Related Targets
HDAC6KDM1AHDAC8

Related

2
Drugs associated with HDAC6 x KDM1A x HDAC8
JBI-097
Target
HDAC6 x HDAC8 x KDM1A
Mechanism
HDAC6 inhibitors [+2]
Active Org.
Jubilant Pharmova Ltd.Jubilant Pharmova Ltd.
Originator Org.
Jubilant Biosys Ltd.Jubilant Biosys Ltd. [+1]
Active Indication
Colonic Cancer [+2]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
iDual
Target
HDAC6 x HDAC8 x KDM1A
Mechanism
HDAC6 modulators [+2]
Active Org.
Sapienza University of RomeSapienza University of Rome
Originator Org.
KOC UniversityKOC University
Active Indication
Lymphoma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with HDAC6 x KDM1A x HDAC8
Login to view more data
100 Translational Medicine associated with HDAC6 x KDM1A x HDAC8
Login to view more data
0 Patents (Medical) associated with HDAC6 x KDM1A x HDAC8
Login to view more data
1
Literatures (Medical) associated with HDAC6 x KDM1A x HDAC8
Cancers
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free